Annual Drug Patent Expirations for RINVOQ+LQ Rinvoq Lq is a drug marketed by Abbvie and is included in one NDA. It is available from one supplier. The generic ingredient in…
Source
Annual Drug Patent Expirations for VOXZOGO Voxzogo is a drug marketed by Biomarin Pharm and is included in one NDA. It is available from one supplier. There are four patents…
Source
Annual Drug Patent Expirations for RINVOQ Rinvoq is a drug marketed by Abbvie and is included in two NDAs. It is available from one supplier. There are thirty-three patents protecting…
Source
Annual Drug Patent Expirations for BRYHALI Bryhali is a drug marketed by Bausch and is included in one NDA. It is available from one supplier. There are three patents protecting…
Source
Annual Drug Patent Expirations for XIGDUO+XR Xigduo Xr is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from two suppliers. There are five…
Source
Annual Drug Patent Expirations for FARXIGA Farxiga is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from five suppliers. There are eighteen patents…
Source
This chart shows the pharmaceutical companies with the most cream dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most cream dosed drugs…
Source
Which pharmaceutical companies have the most cream dosed drugs? Read Post »
ABRAXANE (paclitaxel) Bristol-myers Patent: 8,314,156 Expiration: Jun 9, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
Source
Drug Patent Expirations for the Week of June 9, 2024 Read Post »
Annual Drug Patent Expirations for WELIREG Welireg is a drug marketed by Merck Sharp Dohme and is included in one NDA. It is available from one supplier. There are two…
Source
Annual Drug Patent Expirations for WINLEVI Winlevi is a drug marketed by Sun Pharm and is included in one NDA. It is available from one supplier. There are eight patents…
Source